This SRPT PE ratio history page last updated 2/13/2025

Period | Price | Adj. EPS | TTM | PE |
Q3 2024 11/6/2024 | 127.97 | 0.62 | 2.61 | 49.0 | Q2 2024 8/7/2024 | 140.06 | 0.44 | 2.36 | 59.3 | Q1 2024 5/1/2024 | 130.90 | 0.73 | 1.07 | 122.3 | Q4 2023 2/28/2024 | 137.50 | 0.82 | -0.63 | NA | Q3 2023 11/1/2023 | 76.52 | 0.37 | -1.98 | NA | Q2 2023 8/2/2023 | 105.19 | -0.85 | -3.15 | NA | Q1 2023 5/2/2023 | 123.69 | -0.97 | -3.48 | NA | Q4 2022 2/28/2023 | 122.13 | -0.53 | -3.07 | NA | Q3 2022 11/2/2022 | 113.42 | -0.80 | -3.31 | NA | Q2 2022 8/2/2022 | 94.01 | -1.18 | -2.70 | NA | Q1 2022 5/4/2022 | 72.75 | -0.56 | -3.04 | NA | Q4 2021 3/1/2022 | 76.02 | -0.77 | -4.02 | NA | Q3 2021 11/3/2021 | 86.53 | -0.19 | -5.09 | NA | Q2 2021 8/4/2021 | 67.50 | -1.52 | -6.32 | NA | Q1 2021 5/5/2021 | 72.77 | -1.54 | -6.31 | NA | Q4 2020 3/1/2021 | 87.03 | -1.84 | -5.81 | NA | Q3 2020 11/5/2020 | 145.15 | -1.42 | -5.54 | NA | Q2 2020 8/5/2020 | 158.89 | -1.51 | -5.26 | NA | Q1 2020 5/6/2020 | 122.57 | -1.04 | -4.58 | NA | Q4 2019 2/26/2020 | 113.63 | -1.57 | -4.29 | NA | Q3 2019 11/7/2019 | 93.38 | -1.14 | -3.57 | NA | Q2 2019 8/7/2019 | 142.26 | -0.83 | -2.99 | NA | Q1 2019 5/8/2019 | 114.50 | -0.75 | -2.59 | NA | Q4 2018 2/27/2019 | 151.68 | -0.85 | -2.12 | NA | Q3 2018 10/24/2018 | 123.04 | -0.56 | -1.55 | NA | Q2 2018 8/8/2018 | 121.02 | -0.43 | -1.19 | NA | Q1 2018 5/3/2018 | 78.17 | -0.28 | -1.22 | NA | Q4 2017 3/1/2018 | 62.11 | -0.28 | -1.54 | NA | Q3 2017 10/25/2017 | 48.36 | -0.20 | -1.97 | NA | Q2 2017 7/19/2017 | 34.08 | -0.46 | -2.72 | NA | Q1 2017 4/27/2017 | 34.72 | -0.60 | -3.45 | NA | Q4 2016 2/28/2017 | 31.11 | -0.71 | -4.00 | NA | Q3 2016 10/27/2016 | 40.81 | -0.95 | -4.59 | NA | Q2 2016 7/19/2016 | 21.14 | -1.19 | -4.75 | NA | Q1 2016 5/5/2016 | 16.76 | -1.15 | -4.43 | NA | Q4 2015 2/25/2016 | 14.36 | -1.30 | -4.43 | NA | Q3 2015 11/5/2015 | 24.28 | -1.11 | -4.07 | NA | Q2 2015 8/6/2015 | 34.63 | -0.87 | -3.66 | NA | Q1 2015 5/7/2015 | 15.04 | -1.15 | -3.40 | NA | Q4 2014 2/26/2015 | 13.82 | -0.94 | -2.80 | NA | Q3 2014 11/6/2014 | 16.26 | -0.70 | -2.63 | NA | Q2 2014 8/7/2014 | 19.90 | -0.61 | -2.56 | NA | Q1 2014 5/8/2014 | 31.10 | -0.55 | -2.41 | NA | Q4 2013 2/27/2014 | 29.86 | -0.77 | -2.27 | NA | Q3 2013 11/12/2013 | 13.16 | -0.63 | -3.86 | NA | Q2 2013 8/8/2013 | 36.85 | -0.46 | -5.40 | NA | Q1 2013 5/9/2013 | 33.08 | -0.41 | -4.58 | NA | Q4 2012 3/7/2013 | 30.21 | -2.36 | NA | NA | Q3 2012 11/7/2012 | 22.61 | -2.17 | NA | NA | Q2 2012 8/7/2012 | 8.31 | 0.36 | NA | NA |
|

Period | Price | Adj. EPS | Annualized | PE |
Q3 2024 11/6/2024 | 127.97 | 0.62 | 2.48 | 51.6 | Q2 2024 8/7/2024 | 140.06 | 0.44 | 1.76 | 79.6 | Q1 2024 5/1/2024 | 130.90 | 0.73 | 2.92 | 44.8 | Q4 2023 2/28/2024 | 137.50 | 0.82 | 3.28 | 41.9 | Q3 2023 11/1/2023 | 76.52 | 0.37 | 1.48 | 51.7 | Q2 2023 8/2/2023 | 105.19 | -0.85 | -3.40 | NA | Q1 2023 5/2/2023 | 123.69 | -0.97 | -3.88 | NA | Q4 2022 2/28/2023 | 122.13 | -0.53 | -2.12 | NA | Q3 2022 11/2/2022 | 113.42 | -0.80 | -3.20 | NA | Q2 2022 8/2/2022 | 94.01 | -1.18 | -4.72 | NA | Q1 2022 5/4/2022 | 72.75 | -0.56 | -2.24 | NA | Q4 2021 3/1/2022 | 76.02 | -0.77 | -3.08 | NA | Q3 2021 11/3/2021 | 86.53 | -0.19 | -0.76 | NA | Q2 2021 8/4/2021 | 67.50 | -1.52 | -6.08 | NA | Q1 2021 5/5/2021 | 72.77 | -1.54 | -6.16 | NA | Q4 2020 3/1/2021 | 87.03 | -1.84 | -7.36 | NA | Q3 2020 11/5/2020 | 145.15 | -1.42 | -5.68 | NA | Q2 2020 8/5/2020 | 158.89 | -1.51 | -6.04 | NA | Q1 2020 5/6/2020 | 122.57 | -1.04 | -4.16 | NA | Q4 2019 2/26/2020 | 113.63 | -1.57 | -6.28 | NA | Q3 2019 11/7/2019 | 93.38 | -1.14 | -4.56 | NA | Q2 2019 8/7/2019 | 142.26 | -0.83 | -3.32 | NA | Q1 2019 5/8/2019 | 114.50 | -0.75 | -3.00 | NA | Q4 2018 2/27/2019 | 151.68 | -0.85 | -3.40 | NA | Q3 2018 10/24/2018 | 123.04 | -0.56 | -2.24 | NA | Q2 2018 8/8/2018 | 121.02 | -0.43 | -1.72 | NA | Q1 2018 5/3/2018 | 78.17 | -0.28 | -1.12 | NA | Q4 2017 3/1/2018 | 62.11 | -0.28 | -1.12 | NA | Q3 2017 10/25/2017 | 48.36 | -0.20 | -0.80 | NA | Q2 2017 7/19/2017 | 34.08 | -0.46 | -1.84 | NA | Q1 2017 4/27/2017 | 34.72 | -0.60 | -2.40 | NA | Q4 2016 2/28/2017 | 31.11 | -0.71 | -2.84 | NA | Q3 2016 10/27/2016 | 40.81 | -0.95 | -3.80 | NA | Q2 2016 7/19/2016 | 21.14 | -1.19 | -4.76 | NA | Q1 2016 5/5/2016 | 16.76 | -1.15 | -4.60 | NA | Q4 2015 2/25/2016 | 14.36 | -1.30 | -5.20 | NA | Q3 2015 11/5/2015 | 24.28 | -1.11 | -4.44 | NA | Q2 2015 8/6/2015 | 34.63 | -0.87 | -3.48 | NA | Q1 2015 5/7/2015 | 15.04 | -1.15 | -4.60 | NA | Q4 2014 2/26/2015 | 13.82 | -0.94 | -3.76 | NA | Q3 2014 11/6/2014 | 16.26 | -0.70 | -2.80 | NA | Q2 2014 8/7/2014 | 19.90 | -0.61 | -2.44 | NA | Q1 2014 5/8/2014 | 31.10 | -0.55 | -2.20 | NA | Q4 2013 2/27/2014 | 29.86 | -0.77 | -3.08 | NA | Q3 2013 11/12/2013 | 13.16 | -0.63 | -2.52 | NA | Q2 2013 8/8/2013 | 36.85 | -0.46 | -1.84 | NA | Q1 2013 5/9/2013 | 33.08 | -0.41 | -1.64 | NA | Q4 2012 3/7/2013 | 30.21 | -2.36 | -9.44 | NA | Q3 2012 11/7/2012 | 22.61 | -2.17 | -8.68 | NA | Q2 2012 8/7/2012 | 8.31 | 0.36 | 1.44 | 5.8 |
|
On this page we presented the SRPT PE Ratio History information for Sarepta Therapeutics' stock.
The average SRPT PE ratio history based on using the annualized quarterly earnings result at each measurement period (for the "E" in the PE calculation; and the closing price on earnings date as the "P") is 45.9. Meanwhile, using the trailing twelve month (TTM) quarterly earnings result as our method of calculation the "E" value at each measurement period, the average SRPT PE ratio history based on this TTM earnings result method is 76.9. Note: any PE calculations involving negative earnings were discarded as not meaningful.
Let's now compare this SRPT PE ratio history result, against the recent PE: when this page was posted on 2/12/2025, the most recent closing price for SRPT had been 109.81, and the most recent quarterly earnings result, annualized, was 2.48. Meanwhile, the most recent TTM earnings summed to 2.61. From these numbers, we calculate the recent SRPT PE on 2/12/2025 based on annualized quarterly EPS was 44.3. Based on SRPT's history, that recent PE is low relative to the historical average, with the recent PE 3.5% lower than the historical average PE across our data set for Sarepta Therapeutics. Looking at the recent SRPT PE on 2/12/2025 based on TTM EPS, we calculate the ratio at 42.1. Based on SRPT's history, that recent PE is low relative to the historical average, with the recent PE 45.3% lower than the average PE across our Sarepta Therapeutics data set with TTM EPS used in the calculation at each period.
Another interesting SRPT PE ratio history calculation we look at is to take the median earnings per share of the last four quarters for SRPT, and then annualize the resulting value... with that annualized number then being used in the PE calculation. To walk through this math for SRPT, we start with the past four EPS numbers and we first sort them from lowest to highest: 0.44, 0.62, 0.73, and 0.82. We then toss out the highest and lowest result, and then take the average of those two middle numbers — 0.62 and 0.73 — which gives us the median of 0.68. Basically the way to think about this 0.68 number is this: for the trailing four earnings reports, 0.68 marks the "middle ground" number where SRPT has reported a value higher than 0.68 half the time, and has reported a value lower than 0.68 half the time. Annualizing that median value then gets us to 2.72/share, which we use as the denominator in our next PE calculation. With 109.81 as the numerator (as of 2/12/2025), the calculation is then 109.81 / 2.72 = 40.4 as the SRPT PE ratio as of 2/12/2025, based on that annualized median value we calculated.
For self directed investors doing their due diligence on SRPT or any other given stock, valuation analysis for SRPT
can greatly benefit from studying the past earnings and resulting PE ratio history calculations. This type of study can
help inform an analysis as to whether the earnings trajectory over time and current versus historical average PE ratios
justify the current stock market value.
That's why we bring you HistoricalPERatio.com to make it easy for investors to investigate
Sarepta Therapeutics PE ratio history — or the PE history for any stock in our coverage universe.
And in your continued research we hope you will be sure to check out the further links included for
next earnings dates and also historical earnings surprises history for SRPT. Thanks for visiting, and the next
time you need to research SRPT PE Ratio History or the PE ratio history for another stock, we hope our site
will come to mind as your go-to PE ratio history research resource of choice.